Devices › Ventilator, continuous, facility use
Device brand name · Ventilator continuous facility use
Trilogy O2: medical device reports filed with FDA
4,290 reports name it, 2012–2026. Manufacturer given most often on reports: Respironics. Product code CBK.
- 4,290
- device reports naming the brand
- 0% of all MAUDE reports · about 298 a year
- 48
- reports, 12 months to August 2026
- 192 in the 12 months before
- 98.9%
- classified as malfunction
- 91.8% across the product code
- 0.3%
- classified as death, as reported
- 15 reports · not verified by FDA
FDA's MAUDE database holds 4,290 reports that name the brand "Trilogy O2" (ventilator continuous facility use), received between February 2012 and August 2026; the manufacturer given most often on reports is Respironics. Spellings of one product vary from report to report.
48 reports arrived in the 12 months to August 2026, down 75% from 192 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.9%), injury (0.7%) and death (0.3%); across all ventilator, continuous, facility use reports (product code CBK) death is recorded in 1.1% and malfunction in 91.8%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are circuit failure (39%), failure to recalibrate (18.8%) and device displays incorrect message (12.1%). The patient problems coded most often are no patient involvement, low oxygen saturation and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 213,387 reports carrying product code CBK. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Circuit failure | 1,674 | 39% | 4.5% |
| Failure to recalibrate | 806 | 18.8% | 2.9% |
| Device displays incorrect message | 518 | 12.1% | 9% |
| No display/image | 247 | 5.8% | 5.2% |
| Incorrect or inadequate test results | 231 | 5.4% | 1.2% |
| Device operational issue | 157 | 3.7% | 1.1% |
| Mechanical problema mechanical problem | 132 | 3.1% | 7.4% |
| Failure to charge | 127 | 3% | 2.5% |
| Battery problema problem with the battery | 114 | 2.7% | 4.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 101 | 2.4% | 5.5% |
| Electrical /electronic property probleman electrical or electronic problem | 88 | 2.1% | 3.8% |
| Device maintenance issue | 71 | 1.7% | 0.3% |
| Failure to power up | 41 | 1% | 2.9% |
| Device inoperablethe device could not be used | 40 | 0.9% | 4.3% |
| Self-activation or keying | 38 | 0.9% | 0.5% |
| Failure to calibrate | 34 | 0.8% | 3.3% |
| Contamination | 33 | 0.8% | 0.9% |
| Insufficient device problem information | 28 | 0.7% | 1.2% |
| Incorrect, inadequate or imprecise result or readings | 25 | 0.6% | 0.3% |
| Temperature problem | 20 | 0.5% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 1,562 | 36.4% |
| Low oxygen saturation | 36 | 0.8% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 25 | 0.6% |
| Deaththe patient died; cause not stated by this term | 7 | 0.2% |
| Hypoxialow oxygen | 4 | 0.1% |
| Respiratory distressdifficulty breathing | 3 | 0.1% |
| Cyanosis | 2 | 0% |
| Heart failure/congestive heart failure | 2 | 0% |
| Chronic obstructive pulmonary disease (COPD) | 1 | 0% |
| Coughcough | 1 | 0% |
| Dyspneashortness of breath | 1 | 0% |
| Headachehead pain | 1 | 0% |
| Increased respiratory rate | 1 | 0% |
| Loss of consciousnesspassing out | 1 | 0% |
| Respiratory arrestbreathing stopped | 1 | 0% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Trilogy O2 | Product code CBK | All MAUDE reports |
|---|---|---|---|
| Reports | 4,290 | 213,387 | 26,136,888 |
| Share of that pool | — | 2% | 0% |
| Classified as death, per 1,000 reports | 3 | 11 | 9 |
| Classified as injury | 0.7% | 6.8% | 36.2% |
| Classified as malfunction | 98.9% | 91.8% | 62.3% |
| Filed by the manufacturer | 100% | 95.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code CBK
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Trilogy 100 | 31,022 | 2,056 | 0.9% |
| 840 Ventilator | 18,191 | 27 | 0.4% |
| Hamilton Medical Ag | 10,331 | 0 | 0.3% |
| Trilogy Evo | 8,583 | 943 | 1.1% |
| Vela Ventilator | 8,446 | 0 | 0.3% |
| Servo-I | 6,390 | 3 | 1.3% |
| Esprit Ventilator | 6,015 | 0 | 0.4% |
| Vocsn | 5,308 | 854 | 0.4% |
| Trilogy 202 | 5,217 | 74 | 0.3% |
| Carescape R860 | 4,968 | 50 | 0.2% |
| Carescape | 4,902 | 2,289 | 0.1% |
| 980 Ventilator | 4,651 | 117 | 0.2% |
| Avea Ventilator | 3,943 | 0 | 0.5% |
| V200 Ventilator | 3,476 | 0 | 0.2% |
| Uni-Vent Model 731 | 3,305 | 0 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Trilogy O2 reports
How many FDA reports name Trilogy O2?
4,290 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 48 in the latest 12 months.
What kinds of events are reported?
malfunction (98.9%), injury (0.7%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
circuit failure (39%), failure to recalibrate (18.8%), device displays incorrect message (12.1%), no display/image (5.8%) and incorrect or inadequate test results (5.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Trilogy O2 was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.